Paul Janssen was born 100 years ago
Probably, the most creative and productive pharmaceutical chemist of all time, Dr. Paul Adriaan Jan Janssen, was born 100 years
A forum for researchers, students and applicants in the field of cyclodextrin technology
Probably, the most creative and productive pharmaceutical chemist of all time, Dr. Paul Adriaan Jan Janssen, was born 100 years
This study developed a new vaginal hydrogel to treat genitourinary syndrome of menopause, aiming to improve drug retention and patient
Researchers from Türkiye developed GE11-functionalized curcumin/carboxymethyl-β-cyclodextrin (Cur/CM-βCD) supramolecular assemblies, using GE11 as an EGFR-targeting peptide, to enhance the therapeutic potential
A new chapter in targeted cancer therapy On July 14, 2026, the U.S. FDA approved REVTORPYK™ (gedatolisib), developed by Celcuity,
Researchers from the United States 🇺🇸 developed fast-dissolving HPβCD nanofibers containing a three-drug combination of aspirin, paracetamol, and caffeine commonly
This review on electrospinning investigates how this techniqe can be applied for delivering multiple drugs by allowing precise control over
Remdesivir (REM), a nucleoside analogue that has been approved for SARS-CoV-2 treatment, is poorly soluble in water and is currently
The Chinese group designed novel cyclodextrin-engineered bioinspired nanozyme (T-CD/Pt), and integrate it into a bi-regional microneedle (TP-MNs). Coupled with a
Researchers from Canada 🇨🇦 developed αCD-based nanoparticles to improve the stability and intestinal uptake of curcumin, a bioactive compound limited
This article aims to provide a comprehensive, evidence-based overview of the current and potential roles of cyclodextrins as safe, effective,